You are here: Welcome » Robert Malone

Robert Malone

Dr. Robert Wallace Malone, MD is an American vaccinologist. He is frequently described as the inventor of genetic vaccine technology, including both DNA vaccines and mRNA vaccines.

He has served as Adjunct Associate Professor of Biotechnology at Kennesaw State University, as Associate Professor at the Uniformed Services University of the Health Sciences, as faculty at the University of Maryland Medical School and at the University of California Davis.1)

He claims to have Secret Clearance from the United States Department of Defense (DoD).

He is married to Jill Glasspool-Malone, a fellow biotechnology researcher and entrepreneur. The couple runs a horse breeding business called Cielo Azure Lusitanos equipped with “a full laboratory for stallion collection and foaling capabilities”, including collection and shipping of semen.2)



Malone submitted a letter of resignation to Wick Goodspeed at Vical on August 1, 1989, effective August 25.3)

Robert and his wife, Jill Glasspool-Malone, collaborated in the formation of Inovio Pharmaceuticals, with Jill having reportedly been responsible for incorporating the company.4) 5) The pair also co-founded RW Malone MD, LLC in August 2001. Long-term clients include Avancer Group, Chesapeake Perl, Corium, ITT-Exelis, EpiVax, Jean Brown Research, Quest Diagnostics, PaxVax, SAI, Soligenix, TASC, and the University of Massachusetts.


Malone served as Associate Director of Clinical Research at DynPort Vaccine Company from 2002-2003. His responsibilities included preparing planning documents and product development plans, participating in the safety review of a smallpox vaccine, identification of new technologies, and managing in-house publication.6)

From 2007-2012, Malone served as Editor-In-Chief of the Journal of Immune Based Therapies and Vaccines.


In a slideshow titled “Interpandemic Vaccination Controversy, Challenge, Opportunity”, dated November 5, 2008, Malone described the potential for rapid development and authorization of novel vaccines in response to pandemic strains of influenza.7) Another slideshow, titled “DNA Vaccines: Where did this come from, and where do we go from here?”, dated November 13, 2008, outlined the steps of Malone's development of DNA vaccine technology.8)

Malone served as Medical Director of Vaccines at Accelovance from 2008-2009.9) In this capacity, he delivered a presentation dated November 19, 2018 titled “Vaccine and OTC Product Advancement”.10)

In December 2008, Malone delivered a presentation for BioPractice titled “Emerging And Re-emerging Infectious Diseases: New Vaccine Product Opportunities”.11) He served as medical monitor for multiple studies of seasonal and pandemic influenza.

In June 2010, Malone was hired as Medical Director of Vaccines at the Beardsworth Consulting Group.12) 13) He remained in this position until 2013.14)


In August 2014, Malone was asked by colleagues at the Defense Threat Reduction Agency (DTRA) to help NewLink Genetics (through their subsidiary, BioProtection Systems) manage their Ebola project.15) According to his CV, Malone “built and led the initial team” that “took the Canadian rVSV-ZEBOV-G Ebola vaccine from an abandoned vaccine candidate to funding in the 100 million USD range.”16) This included implementing “effective stockpiling strategies, project planning and clinical trials development for dosing strategies” and recruiting Merck to the project.

Malone participated in the Harvard Medical School Global Clinical Scholars Program in 2015-2016.17)


Malone co-founded Atheric Pharmaceutical in February 2016.18) He co-authored a paper published in March 2016 describing development of medical countermeasures to the Zika virus. His co-authors included Jane Homan, Michael Callahan, Jill Glasspool-Malone, Lambodhar Damodaran, Adriano De Bernardi Schneider, Rebecca Zimler, James Talton, Ronald Cobb, Ivan Ruzic, Julie Smith-Gagen, Daniel Janies and James Wilson.19)

He published a followup study in August 2016 titled Zika Fetal Neuropathogenesis: Etiology of a Viral Syndrome. His co-authors included Zachary Klase, Svetlana Khakhina, Adriano De Bernardi Schneider, Michael Callahan and Jill Glasspool-Malone.20)

Malone worked closely with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) on his analysis of drug compounds.21)

COVID-19 Pandemic

Drug discovery

At some point in 2020, Steve Kirsch reached out to Malone for help applying for an Emergency Use Authorization (EUA) from the Biomedical Advanced Research and Development Authority (BARDA).22)

In early 2020, Michael Callahan reached out to Malone to inform him about the emerging SARS-CoV-2 outbreak in Wuhan, China. By this time, Malone was working with the Defense Threat Reduction Agency (DTRA)'s Discovery of Medical Countermeasures Against Novel Entities (DOMANE) program, through which Malone began investigating famotidine.23) 24) On April 14, BARDA awarded Malone's company, Alchem Laboratories, a $20.7 million contract the conduct a clinical trial on the drug.

On May 24, 2020, Malone published a pre-print study titled “COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms” co-authored with Jill Glasspool-Malone and others.25) It underwent revisions on June 22 and August 31 before being published in Frontiers in Pharmacology on March 23, 2021.

Revising history

On May 21, 2021, Robert and Jill Glasspool-Malone commented on an IPWatchdog article titled “The mRNA IP and Competitive Landscape Through One Year of the COVID-19 Pandemic – Part I” in which the pair complain that he was not credited.26)

Malone appeared in an August 2021 episode of Perspectives on the Pandemic.27)

In September 2021, Malone was interviewed by Jimmy Dore.28) Both men suffered adverse events following injection with COVID-19 vaccines.

Malone points to “second generation” vaccine technology as potentially safer and preferable to current COVID-19 vaccines.29) On September 21, 2021, Dr. Robert Malone pitched Reliance Life Sciences' RelCoVax to an online audience at the Vaccines Summit-2021, an event which he also Chaired.30) 31)

Malone participated in a November 2021 interview with Veronika Kyrylenko of The New American.32)

On December 9, 2021, Malone appeared for a two-hour question and answer session on the Vaccine Safety Research Foundation livestream.33) He then spoke about mRNA Technology on the Courtenay Turner Podcast on December 24, 2021.34)

Malone was deplatformed by Twitter on December 29, 2021 after sharing a video produced by the Canadian Covid Care Alliance titled “The Pfizer Inoculations For COVID-19 – More Harm Than Good.”35) He appeared the following day on the Joe Rogan Experience.36) Malone and Joe Rogan discussed a range of topics including ivermectin, Mattias Desmet's theory of mass formation, and COVID-19 in general.37) Jonathan Witt summarized the episode on Twitter.38) The full transcript from the interview was submitted to the Congressional record by Congressman Troy Nehls on January 3, 2022.39)

Malone suggested that the Indian state of Uttar Pradesh hid its use of ivermectin, which seemed to contradict previous public statements from the state government on the matter.40) 41) Forbes dismissed Malone's “mass formation psychosis” statements as “unfounded.”42)

In January 2022, Malone warned of an “Ebola-like hemorrhagic feversupervirus in China caused by vaccine-induced immune escape.43) The Brownstone Institute published an article on January 6, 2022 defending Malone's role in the invention of mRNA vaccine technology.44)

Malone testified at the National Citizens Inquiry (NCI) in Toronto, Ontario on March 30, 2023, where he discussed the 5th generation of warfare during the COVID-19 pandemic.45)


Conflicts with participants of the medical freedom movement

Peter and Ginger Breggin

The Breggins operate America Out Loud. The Who We Are webpage proclaims that the website is about “American patriots that are Out Loud in their love of our constitution and our way of life”.

Malone has filed a $25.35M defamation lawsuit against the Breggins, American Out Loud, Dr. Jane Ruby, and Red Voice Media. A Substack post by Malone posts a copy of his legal complaint that was filed.

Defendants falsely accused Dr. Malone of fraud, disinformation, dishonesty, deception, lying to the American public, lack of integrity, immorality and ethical improprieties. The gist of the defamatory statements and implications is that Dr. Malone lacks the character and is unfit to be a medical doctor and scientist. Defendants’ statements (describe in haec verba below) exposed Dr. Malone to public ridicule, scorn, and contempt, and severely prejudiced him in his profession and employment.

The Breggins have published blog posts on their side of the story:

Since publicly speaking about the ongoing lawsuit, the Breggins have published a piece critical of Malone. The post, Could This Man Have Saved the World?, contends that Malone should have made professional or public disclosures of the risk of COVID vaccinations with genetic mRNA and DNA.

Paul Alexander

Paul Alexander has publicly attacked Malone for his lawsuit against the Breggins and alleges that Malone has made legal threats against him. Some of his public statements include:

A March 19, 2023 Substack by Robert Malone states: “I have never threatened or taken any legal action against Dr. Paul Alexander.”

Peter McCullough

The March 19, 2023 Substack by Robert Malone possibly alludes to Peter McCullough's involvement with The Wellness Company (which sells supplements or 'vitamins'): “And no, we are not making millions of dollars off of Substack. […] No grifting. No vitamins or drugs being sold by us.” A subsequent section of the same Substack post states Malone's position on Harvey Risch and Peter McCullough:

I have never threatened or taken any legal action in any way against Drs. Harvey Risch or Peter McCullough. I have not “attacked” or demeaned either. I did once disclose their financial entanglements with a company that sells vitamins and nutritional supplements called “The Wellness Company” (which remains the case), but deleted that essay due to objections from their supporters. Anyone who says otherwise is lying. When you hear such statements, please ask for documentation and do not take the comments and assertions of others at face value.

Sage Hana

Sage Hana is the pseudonym of the Substack writer who publishes under that name.

The March 19, 2023 Substack by Robert Malone discusses “professional and financial damages” (against Malone) being perpetrated by 'purveyors of hate'. Malone makes various statements about Sage Hana:

  • “actually a man”
  • “a former (unsuccessful) Democratic party candidate for statewide office in Colorado”
  • “a Lyft driver”
  • Implies that Sage Hana is unqualified to be a professional/expert: “the law recognizes that there are unqualified persons who venture a wide variety of internet opinions, and these generally are not subject to tort protection” and “However, when someone presents themselves as a professional and expert, and repeatedly spreads verifiable defamatory lies about another professional who can be reasonably interpreted as a competitor (for Book or Substack publication revenue, for example), then that becomes a different matter entirely.”
About Us. Cielo Azure Lusitanos. Retrieved March 4, 2023, from
Deigin, Y. (2022, April 9). Robert Malone’s role in the invention of mRNA vaccines — an analysis. Medium.
Robert W Malone, MD [@RWMaloneMD]. (2021, August 26). “Another DNA vaccine candidate. Jill actually did the incorporation for Inovio USA back in the day. We were also very involved in discovery/development of this tech platform when were at UMaryland Baltimore.” [Tweet]. Twitter.
Malone, R. W. (2008, November 5). Interpandemic Vaccination Controversy, Challenge, Opportunity. SlideShare.
Malone, R. W. (2008, November 13). DNA Vaccines: Where did this come from, and where do we go from here? SlideShare.
Malone, R. W. (2008, November 19). Vaccine and OTC Product Advancement. SlideShare.
Malone, R. W. (2008, December 13). Emerging And Re-emerging Infectious Diseases: New Vaccine Product Opportunities. SlideShare.
Martin and Malone join Beardsworth Consulting. (2010, June 30). The Courier-News, 8.
Key Personnel. Beardsworth. Retrieved January 19, 2012, from
15) , 17)
The Team. Atheric Pharmaceutical. Retrieved July 14, 2017, from
Atheric Pharmaceutical LLC. Gust. Retrieved February 25, 2023, from
Malone, R. W., Homan, J., Callahan, M. V., Glasspool-Malone, J., Damodaran, L., Schneider, A. D. B., Zimler, R., Talton, J., Cobb, R. R., Ruzic, I., Smith-Gagen, J., Janies, D., & Wilson, J. (2016). Zika Virus: Medical Countermeasure Development Challenges. PLOS Neglected Tropical Diseases, 10(3), e0004530.
Klase, Z. A., Khakhina, S., Schneider, A. D. B., Callahan, M. V., Glasspool-Malone, J., & Malone, R. (2016). Zika Fetal Neuropathogenesis: Etiology of a Viral Syndrome. PLOS Neglected Tropical Diseases, 10(8), e0004877.
Vaccine Safety Research Foundation. (2023, January 26). Full Episode #64: “Defeat the Mandates Anniversary” with Robert Malone, MD. Rumble.
Borrell, B. (2020). New York clinical trial quietly tests heartburn remedy against coronavirus. Science.
Halford, B. (2020, June 15). Can Pepcid treat COVID-19? Chemical & Engineering News.
Malone, R. W., Tisdall, P., Fremont-Smith, P., Liu, Y., Huang, X.-P., White, K. M., Miorin, L., Olmo, E. M. D., Alon, A., Delaforge, E., Hennecker, C. D., Wang, G., Pottel, J., Bona, R., Smith, N., Hall, J. M., Shapiro, G., Clark, H., Mittermaier, A., & Kruse, A. C. (2020). COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms. Research Square.
Shores, D., Haversack, D., & Storaska, A. J. (2021, April 11). The mRNA IP and Competitive Landscape Through One Year of the COVID-19 Pandemic –Part I. IPWatchdog.
PerspectivesOnThePandemic. (2021, August 30). “Injections & Injunctions” Part 1: Paradox | A Conversation with Dr. Robert Malone. BitChute.
Dore, J. [Jimmy Dore]. (2021, September 14). EXPLOSIVE Truth About Vaccines & COVID w_Inventor Of mRNA Vaccine Technology, Robert Malone [Video]. Rokfin.
Robert W Malone, MD. (2021, September 26). RelCovaxTM, a second-generation multivalent SARS-CoV-2 vaccine. YouTube.
Housatonic. (2023, February 6). (Sep 21 2021) Robert malone: “RelCovax, 2ndGen multivalent SARS-CoV-2 vaccine candidate” (Summit). Rumble.
Kyrylenko, V. (2021, November 9). Dr. Robert Malone: “This is the Largest Experiment Performed on Human Beings in the History of the World.” The New American.
Vaccine Safety Research Foundation. (2021, December 10). EP 07: VSRF’s Weekly Update, Dec 9, 2021: 2 Hour Live Q&A with Dr. Robert Malone. Odysee.
Turner, C. (2021, December 24). Ep 67: The Truth About mRNA Technology With Dr. Robert Malone| The Courtenay Turner Podcast. Rumble.
Campbell, N. (2021, December 31). Here’s What Got MRNA Inventor Robert Malone Banned From Twitter. Vision Times.
WethePeopleUSA. (2022, January 1). Dr. Robert Malone Full Interview By Joe Rogan: Explains How Dire the Situation is in the USA, YouTube Removes Bombshell Viral Video! Rumble.
COVID, Ivermectin, And “Mass Formation Psychosis”: Dr. Robert Malone Gives Blistering Interview To Joe Rogan. (2022, January 1). ZeroHedge.
Acclaimed Journalist [@Jonathan_Witt]. (2021, December 31). “Here’s a thread of cliff notes for the @joerogan podcast with Dr Robert Malone. Would still recommend listening to the full episode but if you don’t have time right now this is how it went down.” [Tweet]. Twitter.
Joe Rogan Experience #1757 - Dr. Robert Malone, MD Full Transcript. (2022, January 3). Nehls.
Seth, M. (2021, May 12). Uttar Pradesh government says early use of Ivermectin helped to keep positivity, deaths low. The Indian Express.
Dutta, D. (2022, January 1). Debunking claim by Dr Robert Malone that India withheld info about Ivermectin from US govt. OpIndia.
Lee, B. Y. (2022, January 2). What Is Mass Formation Psychosis? Robert Malone Makes Unfounded Covid-19 Vaccine Claims On Joe Rogan Show. Forbes.
Ghlionn, J. M. (2022, January 6). The Defenestration of Dr. Robert Malone. Brownstone Institute.
Horwood, M. (2023, March 30). Governments Used “Fifth-Generation Warfare” During COVID, Robert Malone Tells National Citizen’s Inquiry. The Epoch Times.
Back to top